Nordic AML Meeting 2023

Radisson BLU Royal Hotel Bergen, Norway

The Nordic AML meeting is a unique opportunity to learn about the latest clinical and scientific developments in the field of AML. The meeting will feature great keynote speakers from both Nordic countries and around the world. We will have an exciting program that covers a broad range of topics, including novel therapies, clinical trials, genetics, and molecular biology.
We are also excited to offer a poster session, and submission is still open. In addition, poster
presentations from previous conferences as well as interesting case reports are welcome.

Webinar – Immunotherapy: a new perspective for AML maintenance treatment?

Agenda Download a recorded version of the webinar using this link. Find the HCP guide for Ceplene on this link. Ceplene can be ordered with the Nordic item number (Vnr.) 46 54 33, through: Oriola in Sweden TMJ in Denmark Your local wholesaler, Apotek 1, NMD and Alliance in Norway --------------------------------------------- AML patients not candidates to […]

NAMLG TWG Meeting – I – 24-01-2024 15:30-16:30 CET

Link and passcode for Teams meeting sent separately. Agenda: Update on potential LD-VenEx amendment trial comparing poDEC/LD-VenEx vs. AZA/LD-VenEx (5 min + 10 min discussion). NAMLG – platform trial structure concept (5 min): Infrastructure with standing collaboration contracts (clinical trial agreement – CTA) and data processing agreements (DPAs) applicable for all types of trials. This […]

Early Response Evaluation by Single-Cell Signaling Profiling in AML

Webinar to be held January 25 at 16:00 This is in Standard Biotools’ (former Fluidigm) Scientist in the Spotlight series. More info and registration on this link. Hear about: Insights into AML response: Discover the initial signaling response to standard induction chemotherapy in a cohort of 32 AML patients.   Predicting 5-year survival: Learn about the significant predictors of patient […]